We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
SER | Strategic Energy Resources Limited | 0.033 | 0.017 | 106.25% | 103,636,351 | 1,072 |
RR1OA | Reach Resources Ltd | 0.007 | 0.003 | 75.00% | 84,054 | 3 |
KED | Keypath Education International Inc | 0.83 | 0.295 | 55.14% | 499,536 | 92 |
REEO | RareX Limited | 0.003 | 0.001 | 50.00% | 1,158,605 | 3 |
CPOO | Culpeo Minerals Ltd | 0.006 | 0.002 | 50.00% | 526,390 | 1 |
AN1 | Anagenics Ltd | 0.01 | 0.003 | 42.86% | 5,481,308 | 57 |
T3D | 333D Limited | 0.008 | 0.002 | 33.33% | 487,613 | 3 |
GMN | Gold Mountain Limited | 0.004 | 0.001 | 33.33% | 7,853,019 | 16 |
EDE | Eden Innovations Ltd | 0.002 | 0.0005 | 33.33% | 1,914,026 | 4 |
NAE | New Age Exploration Limited | 0.004 | 0.001 | 33.33% | 885,170 | 6 |
FTZ | Fertoz Limited | 0.04 | 0.01 | 33.33% | 33,338 | 3 |
NEW YORK, N.Y., May 21, 2024 (GLOBE NEWSWIRE) -- On May 17, 2024, SCWorx Corp. (the “Company”) received a further notice (the “Notice”) from The Nasdaq Stock Market, LLC (“Nasdaq”) indicating that, as a result of not having timely filed its Form 10-Q for the period ended March 31, 2024, and because it remains delinquent in filing its Form 10-K for the year ended December 31, 2023, the Company has failed to satisfy a standard for continued listing, namely Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic reports with the SEC. ...
TriSalus Life Sciences® Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, announced today that it has commenced an exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) relating to its warrants (the “Warrants”) identified in the Prospectus/Offer to Exchange (as defined below). The purpose of the Offer and Consent Solicitation is to simplify the Company’s capital structure and reduce the potential dilutive impact of the Warrants, thereby providing the Company with more flexibility for financing its operations in the future.
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical Genetics Panel of the U.S. Food and Drug Administration (FDA)’s Medical Devices Advisory Committee has strongly recommended FDA approval of the company’s Shield™ blood test for colorectal cancer (CRC) screening in adults age 45 and older who are at average risk for the disease.
PLEASANTON, Calif., May 24, 2024 /PRNewswire/ -- Workday, Inc. (NASDAQ: WDAY), a leading provider of solutions to help organizations manage their people and money, today announced that Carl Eschenbach, CEO, Workday, will present at the Jefferies Software Conference on May 29, 2024 at 9:00 a.m. Pacific Time / 12:00 p.m. Eastern Time. There will also be a live webcast of the event, available here.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 67,234.15 | -690.43 | -1.02% | 1.32T | 5,704,663,302 |
ETH | Ethereum | 3,695.16 | -80.78 | -2.14% | 444.82B | 9,184,313,401 |
USDT | Tether USD | 0.99935 | -0.00011 | -0.01% | 97.77B | 318,670,093 |
BNB | Binance Coin | 595.87 | -2.89 | -0.48% | 94.24B | 420,150,562 |
SOL | Solana | 166.14 | -9.86 | -5.60% | 73.58B | 1,922,698,915 |
STETH | stETH | 3,693.23 | -81.16 | -2.15% | 36.3B | 54,429,808 |
XRP | Ripple | 0.5334 | 0.0049 | 0.93% | 29.28B | 567,659,188 |
USDC | USD Coin | 1.00 | 0.00 | 0.00% | 28.07B | 1,604,034,710 |
DOGE | Dogecoin | 0.16379 | 0.00416 | 2.61% | 23.55B | 1,008,715,881 |
TONCOIN | Wrapped TON Coin | 6.17 | -0.044815 | -0.72% | 21.37B | 120,508,027 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions